Xiamen Amoytop Biotech Co Ltd (688278) — Cash Flow Quality Index
Xiamen Amoytop Biotech Co Ltd (688278) has a Cash Flow Quality Index of 1.99x as of September 2023. Operating cash flow of CN¥332.29 Million exceeds net income of CN¥166.73 Million, indicating high earnings quality where cash backs reported profits. Explore 688278 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xiamen Amoytop Biotech Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Xiamen Amoytop Biotech Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 688278 cash generation efficiency.
Annual Cash Flow Quality Index for Xiamen Amoytop Biotech Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Xiamen Amoytop Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.52x | CN¥430.63 Million | CN¥827.60 Million | ▼ -43.6% |
| 2023 | 0.92x | CN¥512.10 Million | CN¥555.45 Million | ▼ -27.1% |
| 2022 | 1.27x | CN¥363.16 Million | CN¥287.02 Million | ▼ -2.3% |
| 2021 | 1.30x | CN¥234.78 Million | CN¥181.26 Million | ▲ +62.7% |
| 2020 | 0.80x | CN¥92.61 Million | CN¥116.35 Million | ▼ -58.5% |
| 2019 | 1.92x | CN¥123.30 Million | CN¥64.29 Million | ▼ -65.6% |
| 2018 | 5.57x | CN¥89.15 Million | CN¥16.00 Million | ▲ +352.4% |
| 2017 | -2.21x | CN¥-11.41 Million | CN¥5.17 Million | ▼ -252.5% |
| 2016 | 1.45x | CN¥42.43 Million | CN¥29.31 Million | — |